Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC (Iverped)
Efficacy, Safety and Acceptability of Ascending Doses of Ivermectin in Combination With Albendazole for Trichuris Trichiura Infections in Preschool-aged Children: a Single-blind Randomised Controlled Dose-ranging Trial
Sponsor: Jennifer Keiser
A PHASE2 clinical study on Ascariasis and Hookworm Infections, this trial is completed. The trial is conducted by Jennifer Keiser and has accumulated 8 data snapshots since 2024. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Oct 2025 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
▶ Show 3 earlier versions
-
Mar 2024 — May 2024 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2024 — Mar 2024 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2024 — Feb 2024 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Jennifer Keiser
- Public Health Laboratory Ivo de Carneri
For direct contact, visit the study record on ClinicalTrials.gov .